Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cell-mediated Immune Responses

Cell-mediated Immune Responses

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

7(th) International Immunoglobulin Conference: Poster presentations.

Clinical and experimental immunology·2014

Same author

7th International Immunoglobulin Conference: Poster presentations.

Clinical and experimental immunology·2014

Same author

Efficacy and safety of a new immunoglobulin G product, Gammaplex(®), in primary immunodeficiency diseases.

Clinical and experimental immunology·2010

Same author

Immunodeficiencies.

Clinical and experimental immunology·2009

Same author

Clinical experience with Flebogamma 5% DIF: a new generation of intravenous immunoglobulins in patients with primary immunodeficiency disease.

Clinical and experimental immunology·2009

Same author

Histopathology of HCV infection.

Clinics in liver disease·2004

Search research articles

Related Experiment Video

Updated: Jun 25, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

Cell-mediated immunity in cat-scratch disease.

M A Gerber, P Rapacz, S S Kalter

The Journal of Allergy and Clinical Immunology

|November 1, 1986

Summary

This summary is machine-generated.

Cell-mediated immunity plays a key role in cat-scratch disease (CSD). Lymphocyte responses to cat-scratch antigen in patients with CSD were significantly higher than in controls.

More Related Videos

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Published on: September 26, 2022

Murine Model of Epicutaneously-Induced Immunomodulation

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Related Experiment Videos

Last Updated: Jun 25, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Published on: September 26, 2022

Murine Model of Epicutaneously-Induced Immunomodulation

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Area of Science:

Immunology
Infectious Diseases
Microbiology

Background:

Cell-mediated immunity is implicated in cat-scratch disease (CSD) due to skin test reactions and granulomatous inflammation.
Previous studies showed lymphocytes from CSD patients and controls had similar unresponsiveness to cat-scratch antigen in vitro.

Purpose of the Study:

To investigate lymphocyte transformation responses to cat-scratch antigen in patients with CSD.
To clarify the role of cell-mediated immunity in the pathogenesis of CSD.

Main Methods:

Lymphocyte transformation assays were performed using cat-scratch antigen.
Responses were compared between 16 patients diagnosed with CSD and healthy control subjects.

Main Results:

Patients with CSD exhibited significantly increased lymphocyte transformation responses to cat-scratch antigen compared to control subjects.
This indicates a heightened cellular immune response specific to the CSD pathogen in affected individuals.

Conclusions:

The study demonstrates a robust cell-mediated immune response in CSD patients against cat-scratch antigen.
This immune response likely targets nonviable bacteria in lymph nodes, driving the granulomatous reactions and clinical manifestations of CSD.